KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data shows that the ongoing outbreak has expanded into six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. The Ministry of Public Health and Prevention reports that there have been 5,713 confirmed cases and 2,744 deaths so far. The overall case fatality rate among confirmed patients remains at approximately 48%.
In response to the health crisis, international agencies such as the World Health Organization are providing logistical support, laboratory testing, and vaccine distribution assistance to local medical teams. Authorities are utilizing the Ervebo vaccine under a compassionate-use program while observational data on its effectiveness against the circulating viral strain is being collected by medical researchers. DR Congo has initiated an Ebola vaccination campaign as health workers step up ring-vaccination efforts around identified infection clusters to contain the spread of the virus.
Health Ministry Focuses on Allocating Ervebo to Frontline Medical Staff in Kisangani
Operational challenges such as difficult regional infrastructure, ongoing security concerns, and high mobility across border districts complicate logistical efforts. Kisangani has established cold-chain supply networks to maintain the ultra-low temperatures necessary for vaccine preservation before distribution to remote health zones. The launch of the Ebola vaccination campaign is complemented by civil defense and community health workers conducting outreach programs to enhance disease surveillance and reporting systems.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working alongside local response teams to monitor adverse reactions and assess immune responses among vaccinated populations. Health officials stressed that early clinical detection, combined with isolation protocols and supportive treatments, remains critical to improving patient survival rates. Further vaccine shipments are planned as regional distribution efforts extend to secondary health districts to increase coverage.
Authorities Reinforce Strict Infection Control Procedures in Ebola Treatment Facilities
National response teams are actively expanding contact-tracing activities across urban and rural zones in the eastern region. Local health centers are receiving protective gear, diagnostic reagents, and treatment supplies to bolster their preparedness. The government emphasized that comprehensive public health measures will stay in effect until transmission rates show consistent decline across all affected provinces.
Officials appealed to communities to fully cooperate with mobile vaccination teams and follow established health protocols. Increasing immunization coverage among high-risk groups is expected to stabilize infection numbers in the upcoming weeks. Continued surveillance at transportation hubs and border crossings aims to prevent further geographic spread of the virus.